Oppenheimer & Co. Inc. - Medical Equipment - Advisory Profile

  • September 2013
  • -
  • Global Data
  • -
  • 105 pages

Summary

Oppenheimer & Co. Inc. is an investment bank and firm. It provides financial services and advice to high net worth investors, individuals, businesses and institutions.

GlobalData’s Oppenheimer & Co. Inc. - Medical Equipment - Advisory Profile provides an overview of the deals advised by Oppenheimer & Co. Inc. in the Medical Devices market. The report is an essential source of information for Medical Devices companies, which require the services of financial/legal advisors in their area/region for raising capital or acquiring a company. The report summarizes Oppenheimer & Co. Inc.'s deals for the past five years segregated into year, deal type, segment and geography.

Scope

- Provides essential information on the financial deals in which the firm provided financial/legal advisory services. The deals include mergers and acquisitions, asset financing, asset transactions, private equity / venture capital deals, equity offerings, debt offerings, partnerships, and licensing agreements
- Outlines key advisor information for business intelligence needs such as name, business overview, location and contact information
- Analyzes the advisor’s deals by year, deal type, segment and geography
- Provides detailed information on deal particulars, including information about other advisors involved in the deal
- Includes information on the role played by the advisor in specific deals, and the extent of fees/commission charged by the advisor in a particular transaction, if disclosed
- Consists of Deals Advised by Year chart and table displaying information on the number of deals and value reported by the advisor by year, for a five year period
- Incorporates information on the major recent financial deals of the advisor. Each such deal carries a Summary, deal type, deal rationale, deal financials and target company’s key financial metrics and ratios (financials are available for major public companies).

Reasons to Buy

- Receive detailed information and evaluate the profile of a particular advisor in the market before considering for your business needs
- Peruse all the advisor’s deals in the Industry market
- Access detailed information about the advisor’s financial deals for the past five years that enable you to scrutinize the key deals, which have shaped investment policies
- Identify other potential advisors currently active in your industry, or industry that you wish to foray into
- Compare your advisory services vis-à-vis your competitors’
- Check and identify the advisor that suits your requirements, such as placement agents, book-runners and underwriters
- Examine the breakdown of deals by category and detailed information on major deals incorporated in the advisor’s profile for your academic or business research needs and their suitability to your requirements.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Oppenheimer and Co. Inc., Medical Equipment Deals Advised By Year, 2007 to YTD 2013 5
Oppenheimer and Co. Inc., Medical Equipment Deals Advised By Type, 2007 to YTD 2013 6
Oppenheimer and Co. Inc., Medical Equipment Deals Advised By Region, 2007 to YTD 2013 7
Oppenheimer and Co. Inc., Medical Equipment Deals Advised By Market, 2007 to YTD 2013 8
Oppenheimer and Co. Inc., Medical Equipment Deals Advised Summary, 2007 to YTD 2013 9
Oppenheimer and Co. Inc., Medical Equipment, Deal Details 13
Acquisition 13
Integra LifeSciences Acquires SeaSpine 13
LabCorp Completes Acquisition Of Orchid Cellmark For US$85 Million 15
Hanger Orthopedic Completes Acquisition Of Accelerated Care Plus 18
HealthTronics Completes Acquisition Of Endocare 20
Inverness Medical Innovations Acquires Matritech 22
Asset Transactions 23
Sorin Acquires Cannulae Product Line From ESTECH 23
Debt Offerings 24
InspireMD Completes Private Placement Of Convertible Debentures Due 2014 For US$11 Million 24
Integra LifeSciences Holdings Completes Private Placement Of Convertible Senior Notes Due 2016 For US$230 Million 25
Hanger Orthopedic Completes Private Placement Of Senior Notes Due 2018 For US$200 Million 27
Equity Offerings 28
Vermillion Completes Private Placement Of US$20.6 Million 28
BioForm Medical Completes IPO Of US$92 Million 30
Antares Pharma Completes Private Placement Of US$16 Million 31
STARLIMS Technologies Completes Public Offering Of US$30.05 Million 33
Cardium Therapeutics Completes Private Placement Of US$21.5 Million 35
Rosetta Genomics Completes IPO For US$30 Million 37
Celldex Therapeutics Completes Underwriters' Exercise Of Over-Allotment Option For US$46 Million 39
Sequenom Completes Public Offering Of Common Stock For US$62 Million 41
Microvision Completes Public Offering Of Units For US$10.5 Million 43
Zogenix Completes Public Offering Of Common Stock For US$61.4 Million 45
Derma Sciences Completes Private Placement For US$29 Million 47
Stereotaxis Completes Underwritten Public Offering Of US$16.79 Million 49
Organovo Completes Public Offering Of Shares For US$46.6 Million 51
Kamada Completes Public Offering Of Shares For US$59 Million 52
Immunomedics Completes Public Offering Of Common Stock For US$16 Million 54
Celldex Therapeutics Completes Public Offering Of Shares For US$104 Million 56
Derma Sciences Completes Public Offering Of Shares For US$36 Million 58
Cleveland BioLabs Completes Public Offering Of Units For US$17 Million 60
Fluidigm Completes Public Offering Of Common Stock For US$60 Million 62
Globus Medical Completes IPO For US$25 Million 64
MicroVision Completes Public Offering Of Units For US$10.5 Million 66
Stereotaxis Completes Private Placement Of Shares For US$10 Million 67
Emdeon Completes IPO Of US$166.24 Million 68
SEQUENOM Completes Public Offering Of US$98.04 Million 70
Derma Sciences Completes Private Placement Of US$6.1 Million 72
AspenBio Pharma Completes Private Placement Of US$18 Million 73
North American Scientific Completes Private Placement Of US$15.5 Million 75
Derma Sciences Completes Private Placement Of US$6 Million 76
SEQUENOM Completes Private Placement of US$30.45 Million 78
Zogenix Completes IPO For US$57.7 Million 80
Uroplasty Completes Underwritten Public Offering Of Common Stock For US$16.1 Million 82
Aeroflex Holding Completes IPO Of US$267 Million 83
Aastrom Biosciences Completes Underwritten Public Offering Of US$14 Million 85
Microvision Completes Public Offering Of Common Stock For US$9.9 Million 87
Oncolytics Biotech Announces Exercise Of Underwriter's Allotment Option 89
Alimera Sciences Completes IPO For US$72 Million 91
Stereotaxis Completes Public Offering Of US$30 Million 93
Kraton Performance Polymers Completes IPO For US$139 Million 95
SXC Health Solutions Completes Public Offering For US$214.76 Million 97
Seattle Genetics Completes Public Offering Of US$136 Million 99
Antares Pharma Completes Private Placement Of Units For US$8.5 Million 101
Electro-Optical Sciences Completes Registered Direct Offering Of US$15 Million 103
Appendix 105
Methodology 105
About GlobalData 105
Contact Us 105
Disclaimer 105

List of Tables
Oppenheimer and Co. Inc., Key Facts 1
Oppenheimer and Co. Inc., Medical Equipment Deals Advised Summary, 2007 to YTD 2013 1
Oppenheimer and Co. Inc., Medical Equipment Deals Advised By Year, 2007 to YTD 2013 5
Oppenheimer and Co. Inc., Medical Equipment Deals Advised By Type, 2007 to YTD 2013 6
Oppenheimer and Co. Inc., Medical Equipment Deals Advised By Region, 2007 to YTD 2013 7
Oppenheimer and Co. Inc. Deals Advised By Market, 2007 to YTD 2013 8
Oppenheimer and Co. Inc., Medical Equipment Deals Advised Summary, 2007 to YTD 2013 9
Integra LifeSciences Acquires SeaSpine 13
LabCorp Completes Acquisition Of Orchid Cellmark For US$85 Million 15
Hanger Orthopedic Completes Acquisition Of Accelerated Care Plus 18
HealthTronics Completes Acquisition Of Endocare 20
Inverness Medical Innovations Acquires Matritech 22
Sorin Acquires Cannulae Product Line From ESTECH 23
InspireMD Completes Private Placement Of Convertible Debentures Due 2014 For US$11 Million 24
Integra LifeSciences Holdings Completes Private Placement Of Convertible Senior Notes Due 2016 For US$230 Million 25
Hanger Orthopedic Completes Private Placement Of Senior Notes Due 2018 For US$200 Million 27
Vermillion Completes Private Placement Of US$20.6 Million 28
BioForm Medical Completes IPO Of US$92 Million 30
Antares Pharma Completes Private Placement Of US$16 Million 31
STARLIMS Technologies Completes Public Offering Of US$30.05 Million 33
Cardium Therapeutics Completes Private Placement Of US$21.5 Million 35
Rosetta Genomics Completes IPO For US$30 Million 37
Celldex Therapeutics Completes Underwriters' Exercise Of Over-Allotment Option For US$46 Million 39
Sequenom Completes Public Offering Of Common Stock For US$62 Million 41
Microvision Completes Public Offering Of Units For US$10.5 Million 43
Zogenix Completes Public Offering Of Common Stock For US$61.4 Million 45
Derma Sciences Completes Private Placement For US$29 Million 47
Stereotaxis Completes Underwritten Public Offering Of US$16.79 Million 49
Organovo Completes Public Offering Of Shares For US$46.6 Million 51
Kamada Completes Public Offering Of Shares For US$59 Million 52
Immunomedics Completes Public Offering Of Common Stock For US$16 Million 54
Celldex Therapeutics Completes Public Offering Of Shares For US$104 Million 56
Derma Sciences Completes Public Offering Of Shares For US$36 Million 58
Cleveland BioLabs Completes Public Offering Of Units For US$17 Million 60
Fluidigm Completes Public Offering Of Common Stock For US$60 Million 62
Globus Medical Completes IPO For US$25 Million 64
MicroVision Completes Public Offering Of Units For US$10.5 Million 66
Stereotaxis Completes Private Placement Of Shares For US$10 Million 67
Emdeon Completes IPO Of US$166.24 Million 68
SEQUENOM Completes Public Offering Of US$98.04 Million 70
Derma Sciences Completes Private Placement Of US$6.1 Million 72
AspenBio Pharma Completes Private Placement Of US$18 Million 73
North American Scientific Completes Private Placement Of US$15.5 Million 75
Derma Sciences Completes Private Placement Of US$6 Million 76
SEQUENOM Completes Private Placement of US$30.45 Million 78
Zogenix Completes IPO For US$57.7 Million 80
Uroplasty Completes Underwritten Public Offering Of Common Stock For US$16.1 Million 82
Aeroflex Holding Completes IPO Of US$267 Million 83
Aastrom Biosciences Completes Underwritten Public Offering Of US$14 Million 85
Microvision Completes Public Offering Of Common Stock For US$9.9 Million 87
Oncolytics Biotech Announces Exercise Of Underwriter's Allotment Option 89
Alimera Sciences Completes IPO For US$72 Million 91
Stereotaxis Completes Public Offering Of US$30 Million 93
Kraton Performance Polymers Completes IPO For US$139 Million 95
SXC Health Solutions Completes Public Offering For US$214.76 Million 97
Seattle Genetics Completes Public Offering Of US$136 Million 99
Antares Pharma Completes Private Placement Of Units For US$8.5 Million 101
Electro-Optical Sciences Completes Registered Direct Offering Of US$15 Million 103

List of Figures
Oppenheimer and Co. Inc., Medical Equipment Deals Advised by Deal Type, 2007 to YTD 2013 1
Oppenheimer and Co. Inc., Medical Equipment Deals Advised By Year, 2007 to YTD 2013 1
Oppenheimer and Co. Inc., Medical Equipment Deals Advised By Region, 2007 to YTD 2013 1
Oppenheimer and Co. Inc., Medical Equipment Deals Advised By Market, 2007 to YTD 2013 1
Oppenheimer and Co. Inc., Medical Equipment Deals Advised By Year, 2007 to YTD 2013 5
Oppenheimer and Co. Inc., Medical Equipment Deals Advised by Deal Type, 2007 to YTD 2013 6
Oppenheimer and Co. Inc., Medical Equipment Deals Advised By Region, 2007 to YTD 2013 7
Oppenheimer and Co. Inc., Medical Equipment Deals Advised by Market, 2007 to YTD 2013 8

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Wound Management Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Wound Management Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

YAMASHITA MEDICAL INSTRUMENTS CO., LTD. (Symbol:3022) SWOT Analysis, Strategy, Revenues and Profits

YAMASHITA MEDICAL INSTRUMENTS CO., LTD. (Symbol:3022) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Jiangsu Yuyue medical equipment & supply Co., Ltd. (002223) - Financial and Strategic SWOT Analysis Review

Jiangsu Yuyue medical equipment & supply Co., Ltd. (002223) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Jiangsu Yuwell Medical Equipment & Supply co.,Ltd (Jiangsu Yuwell) is a medical equipment company. The company manufactures and distributes medical equipment for healthcare organizations. It offers ...


1 Companies

Company Profiles

Craigslist Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.